Ocular Therapeutix (OCUL) Assets Average (2014 - 2026)

Ocular Therapeutix's Assets Average history runs 13 years deep, the most recent figure standing at $770.3 million for Q1 2026.

• In Q1 2026, Assets Average rose 78.34% year-over-year to $770.3 million; the TTM figure through Mar 2026 stood at $770.3 million (up 78.34% YoY), while the FY2025 annual figure was $633.0 million, up 78.31% from the prior year.
• Assets Average was $770.3 million for Q1 2026 at Ocular Therapeutix, up from $609.5 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $770.3 million in Q1 2026 to a low of $125.6 million in Q2 2023.
• Historically, Assets Average has averaged $346.1 million across 5 years, with a median of $395.5 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Assets Average slumped 30.38% in 2023, then surged 320.51% in 2024.
• A 5-year view of Assets Average shows it stood at $153.9 million in 2022, then surged by 34.62% to $207.2 million in 2023, then surged by 128.81% to $474.2 million in 2024, then grew by 28.54% to $609.5 million in 2025, then gained by 26.39% to $770.3 million in 2026.
• The last three Assets Average figures came in at $770.3 million (Q1 2026), $609.5 million (Q4 2025), and $431.1 million (Q3 2025), per Business Quant data.